000 01484 a2200421 4500
005 20250513132549.0
264 0 _c19980102
008 199801s 0 0 eng d
022 _a0008-543X
024 7 _a10.1002/(sici)1097-0142(19971215)80:12+<2618::aid-cncr37>3.3.co;2-p
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGautherot, E
245 0 0 _aTherapy for colon carcinoma xenografts with bispecific antibody-targeted, iodine-131-labeled bivalent hapten.
_h[electronic resource]
260 _bCancer
_cDec 1997
300 _a2618-23 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntibodies, Bispecific
_xtherapeutic use
650 0 4 _aColonic Neoplasms
_xradiotherapy
650 0 4 _aFemale
650 0 4 _aHaptens
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aIodine Radioisotopes
_xtherapeutic use
650 0 4 _aMice
650 0 4 _aNeoplasm Transplantation
650 0 4 _aRadioimmunotherapy
650 0 4 _aRadiotherapy Dosage
650 0 4 _aTissue Distribution
650 0 4 _aTransplantation, Heterologous
700 1 _aBouhou, J
700 1 _aLe Doussal, J M
700 1 _aManetti, C
700 1 _aMartin, M
700 1 _aRouvier, E
700 1 _aBarbet, J
773 0 _tCancer
_gvol. 80
_gno. 12 Suppl
_gp. 2618-23
856 4 0 _uhttps://doi.org/10.1002/(sici)1097-0142(19971215)80:12+<2618::aid-cncr37>3.3.co;2-p
_zAvailable from publisher's website
999 _c9376315
_d9376315